Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Parenteral (Subcutaneous Injection)
1.3 Market by Application
1.3.1 Global Opioid Induced Constipation Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation Treatment Market Perspective (2018-2033)
2.2 Opioid Induced Constipation Treatment Growth Trends by Region
2.2.1 Global Opioid Induced Constipation Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Opioid Induced Constipation Treatment Historic Market Size by Region (2018-2023)
2.2.3 Opioid Induced Constipation Treatment Forecasted Market Size by Region (2024-2033)
2.3 Opioid Induced Constipation Treatment Market Dynamics
2.3.1 Opioid Induced Constipation Treatment Industry Trends
2.3.2 Opioid Induced Constipation Treatment Market Drivers
2.3.3 Opioid Induced Constipation Treatment Market Challenges
2.3.4 Opioid Induced Constipation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Treatment Players by Revenue
3.1.1 Global Top Opioid Induced Constipation Treatment Players by Revenue (2018-2023)
3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Opioid Induced Constipation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Induced Constipation Treatment Revenue
3.4 Global Opioid Induced Constipation Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Treatment Revenue in 2022
3.5 Opioid Induced Constipation Treatment Key Players Head office and Area Served
3.6 Key Players Opioid Induced Constipation Treatment Product Solution and Service
3.7 Date of Enter into Opioid Induced Constipation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Induced Constipation Treatment Breakdown Data by Type
4.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2018-2023)
4.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2024-2033)
5 Opioid Induced Constipation Treatment Breakdown Data by Application
5.1 Global Opioid Induced Constipation Treatment Historic Market Size by Application (2018-2023)
5.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Opioid Induced Constipation Treatment Market Size (2018-2033)
6.2 North America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Opioid Induced Constipation Treatment Market Size by Country (2018-2023)
6.4 North America Opioid Induced Constipation Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Induced Constipation Treatment Market Size (2018-2033)
7.2 Europe Opioid Induced Constipation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Opioid Induced Constipation Treatment Market Size by Country (2018-2023)
7.4 Europe Opioid Induced Constipation Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Constipation Treatment Market Size (2018-2033)
8.2 Asia-Pacific Opioid Induced Constipation Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioid Induced Constipation Treatment Market Size (2018-2033)
9.2 Latin America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Opioid Induced Constipation Treatment Market Size by Country (2018-2023)
9.4 Latin America Opioid Induced Constipation Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Constipation Treatment Market Size (2018-2033)
10.2 Middle East & Africa Opioid Induced Constipation Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Opioid Induced Constipation Treatment Introduction
11.2.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Opioid Induced Constipation Treatment Introduction
11.3.4 Pfizer Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 S.L.A. Pharma
11.4.1 S.L.A. Pharma Company Detail
11.4.2 S.L.A. Pharma Business Overview
11.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Introduction
11.4.4 S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.4.5 S.L.A. Pharma Recent Development
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Detail
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.5.5 AIKO Biotechnology Recent Development
11.6 Cubist Pharmaceuticals
11.6.1 Cubist Pharmaceuticals Company Detail
11.6.2 Cubist Pharmaceuticals Business Overview
11.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.6.4 Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.6.5 Cubist Pharmaceuticals Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Detail
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.7.4 Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Introduction
11.8.4 Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2018-2023)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral (Subcutaneous Injection)
Table 4. Global Opioid Induced Constipation Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Opioid Induced Constipation Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Opioid Induced Constipation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Opioid Induced Constipation Treatment Market Share by Region (2018-2023)
Table 8. Global Opioid Induced Constipation Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Opioid Induced Constipation Treatment Market Share by Region (2024-2033)
Table 10. Opioid Induced Constipation Treatment Market Trends
Table 11. Opioid Induced Constipation Treatment Market Drivers
Table 12. Opioid Induced Constipation Treatment Market Challenges
Table 13. Opioid Induced Constipation Treatment Market Restraints
Table 14. Global Opioid Induced Constipation Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Opioid Induced Constipation Treatment Market Share by Players (2018-2023)
Table 16. Global Top Opioid Induced Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation Treatment as of 2022)
Table 17. Ranking of Global Top Opioid Induced Constipation Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Opioid Induced Constipation Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Opioid Induced Constipation Treatment Product Solution and Service
Table 21. Date of Enter into Opioid Induced Constipation Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Opioid Induced Constipation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Opioid Induced Constipation Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Opioid Induced Constipation Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Opioid Induced Constipation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Opioid Induced Constipation Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Opioid Induced Constipation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Opioid Induced Constipation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Opioid Induced Constipation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Opioid Induced Constipation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Opioid Induced Constipation Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Opioid Induced Constipation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Opioid Induced Constipation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Opioid Induced Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. GlaxoSmithKline Company Detail
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Opioid Induced Constipation Treatment Product
Table 49. GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Opioid Induced Constipation Treatment Product
Table 54. AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Opioid Induced Constipation Treatment Product
Table 59. Pfizer Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. S.L.A. Pharma Company Detail
Table 62. S.L.A. Pharma Business Overview
Table 63. S.L.A. Pharma Opioid Induced Constipation Treatment Product
Table 64. S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 65. S.L.A. Pharma Recent Development
Table 66. AIKO Biotechnology Company Detail
Table 67. AIKO Biotechnology Business Overview
Table 68. AIKO Biotechnology Opioid Induced Constipation Treatment Product
Table 69. AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 70. AIKO Biotechnology Recent Development
Table 71. Cubist Pharmaceuticals Company Detail
Table 72. Cubist Pharmaceuticals Business Overview
Table 73. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Product
Table 74. Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 75. Cubist Pharmaceuticals Recent Development
Table 76. Salix Pharmaceuticals Company Detail
Table 77. Salix Pharmaceuticals Business Overview
Table 78. Salix Pharmaceuticals Opioid Induced Constipation Treatment Product
Table 79. Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 80. Salix Pharmaceuticals Recent Development
Table 81. Takeda Pharmaceutical Company Detail
Table 82. Takeda Pharmaceutical Business Overview
Table 83. Takeda Pharmaceutical Opioid Induced Constipation Treatment Product
Table 84. Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2018-2023) & (US$ Million)
Table 85. Takeda Pharmaceutical Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Induced Constipation Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Opioid Induced Constipation Treatment Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Parenteral (Subcutaneous Injection) Features
Figure 5. Global Opioid Induced Constipation Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Opioid Induced Constipation Treatment Market Share by Application: 2022 VS 2033
Figure 7. Drug Store Case Studies
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Opioid Induced Constipation Treatment Report Years Considered
Figure 10. Global Opioid Induced Constipation Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Opioid Induced Constipation Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Opioid Induced Constipation Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global Opioid Induced Constipation Treatment Market Share by Players in 2022
Figure 14. Global Top Opioid Induced Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Opioid Induced Constipation Treatment Revenue in 2022
Figure 16. North America Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Opioid Induced Constipation Treatment Market Share by Country (2018-2033)
Figure 18. United States Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Opioid Induced Constipation Treatment Market Share by Country (2018-2033)
Figure 22. Germany Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Opioid Induced Constipation Treatment Market Share by Region (2018-2033)
Figure 30. China Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Opioid Induced Constipation Treatment Market Share by Country (2018-2033)
Figure 38. Mexico Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Opioid Induced Constipation Treatment Market Share by Country (2018-2033)
Figure 42. Turkey Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Opioid Induced Constipation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. GlaxoSmithKline Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 45. AstraZeneca Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 46. Pfizer Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 47. S.L.A. Pharma Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 48. AIKO Biotechnology Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 49. Cubist Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 50. Salix Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 51. Takeda Pharmaceutical Revenue Growth Rate in Opioid Induced Constipation Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed